<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02833025</url>
  </required_header>
  <id_info>
    <org_study_id>1000053849</org_study_id>
    <nct_id>NCT02833025</nct_id>
  </id_info>
  <brief_title>Point-of-care Assessment of Thrombin Generation and Platelet Function in Children Requiring Cardiopulmonary Bypass</brief_title>
  <official_title>Point-of-care Assessment of Thrombin Generation and Platelet Function in Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hospital for Sick Children</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Synapse B.V. Research Institute, University of Maastricht</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Hospital for Sick Children</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Coagulopathy after cardiopulmonary bypass (CPB) is associated with increased morbidity and
      mortality. Clot formation and clot stability are important factors in coagulation and
      hemostasis. As such platelet dysfunction and impaired thrombin generation play a central role
      in bleeding after cardiac surgery. The primary objective of this study is to evaluate the
      relationship between point-of-care determined platelet function and thrombin generation and
      postoperative bleeding in infants and young children undergoing cardiac surgery with
      cardiopulmonary bypass adjusting for clinically important confounding factors.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative chest tube blood loss</measure>
    <time_frame>24hr</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative chest tube blood loss</measure>
    <time_frame>6hr</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative chest tube blood loss</measure>
    <time_frame>12hr</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfusion of blood products</measure>
    <time_frame>24hr</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>within 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>through study completion, an average of less than one month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>within 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>within 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inotropes</measure>
    <time_frame>within 30 days</time_frame>
    <description>Duration of inotropic support</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kidney injury</measure>
    <time_frame>within 30 days</time_frame>
    <description>Acute kidney injury</description>
  </secondary_outcome>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Platelet Function Tests</condition>
  <condition>Thrombin Generation Tests</condition>
  <condition>Perioperative Coagulopathy</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Thrombin generation and Platelet Function Testing</intervention_name>
    <description>Point-of-care testing of thrombin generation, platelet function, and rotational thromboelastometry</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Children aged ≤5 years undergoing cardiac surgery with cardiopulmonary bypass
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ≤5 years

          2. Undergoing cardiac surgery with cardiopulmonary bypass

        Exclusion Criteria:

          1. Non-english speaking parents/care-givers

          2. Refusal to consent

          3. Extracorporeal membrane oxygenation (ECMO) or ventricular assist device prior to
             surgery

          4. Therapeutic heparin use (unfractionated or low molecular weight) in the immediate
             preoperative period (&lt;12 hr)

          5. Weight &lt;3 kg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James D O'Leary, MBBCh, MM, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hospital for Sick Children</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>James D O'Leary</last_name>
    <phone>416-813-7654</phone>
    <phone_ext>228845</phone_ext>
    <email>james.oleary@sickkids.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2016</study_first_submitted>
  <study_first_submitted_qc>July 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2016</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Hospital for Sick Children</investigator_affiliation>
    <investigator_full_name>James O'Leary</investigator_full_name>
    <investigator_title>Staff Anesthesiologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Hemostatic Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

